Kelun Biotech partner reports positive asthma Phase 2 trial results
Windward Bio reported positive interim Phase 2 POLARIS 1 trial results for asthma drug candidate SKB378 WIN378 and initiated a global Phase 3 study alongside partner Kelun Biotech
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.